Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Mar. 31, 2017
Current assets:    
Cash and cash equivalents $ 10,066 $ 17,461
Accounts receivable, net 1,537 2,108
Inventories 2,865 2,221
Prepaid expenses and other current assets 1,547 616
Current portion of deferred consideration, net of discount 239 237
Total current assets 16,254 22,643
Property and equipment, net 1,136 1,239
Deferred consideration, net of discount, less current portion 1,322 1,497
Other assets 494 80
Total assets 19,206 25,459
Current liabilities:    
Accounts payable 1,272 1,255
Accrued expenses and other current liabilities 1,406 1,302
Deferred revenue 147 345
Deferred revenue Invekra (Note 4) 59 176
Current portion of long-term debt 230 123
Current portion of capital leases 147 74
Taxes payable 13
Total current liabilities 3,261 3,288
Long-term deferred revenue Invekra (Note 4) 443 527
Long-term debt, less current portion 32 45
Long-term capital leases, less current portion 144 168
Total liabilities 3,880 4,028
Stockholders' Equity    
Convertible preferred stock, $0.0001 par value; 714,286 shares authorized, none issued and outstanding at March 31, 2018 and March 31, 2017, respectively 0 0
Common stock, $0.0001 par value; 12,000,000 shares authorized at March 31, 2018 and March 31, 2017, 6,171,736 and 4,289,322 shares issued and outstanding at March 31, 2018 and March 31, 2017, respectively (Note 13) 1 1
Additional paid-in capital 176,740 168,709
Accumulated deficit (157,440) (143,101)
Accumulated other comprehensive loss (3,975) (4,178)
Total stockholders' equity 15,326 21,431
Total liabilities and stockholders' equity $ 19,206 $ 25,459